NCT06508567View on ClinicalTrials.gov

Salvage MR-guided High-Dose-Rate Brachytherapy for Prostate Bed Recurrence After Radiotherapy in the PSMA PET Scan Era

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 8, 2024

Primary Completion Date

August 8, 2026

Study Completion Date

March 1, 2031

Conditions
Prostate Cancer RecurrentProstate Cancer
Interventions
RADIATION

High Dose Rate Brachytherapy

2 fractions of MRI-guided HDR Brachytherapy (13Gy each) delivered over 14 days (± 7 days).

Trial Locations (1)

M5G1Z5

RECRUITING

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER